125 related articles for article (PubMed ID: 15743207)
1. Searching for a reliable orientation of ligands in their binding site: comparison between a structure-based (Glide) and a ligand-based (FIGO) approach in the case study of PDE4 inhibitors.
Gratteri P; Bonaccini C; Melani F
J Med Chem; 2005 Mar; 48(5):1657-65. PubMed ID: 15743207
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking study and development of an empirical binding free energy model for phosphodiesterase 4 inhibitors.
Oliveira FG; Sant'Anna CM; Caffarena ER; Dardenne LE; Barreiro EJ
Bioorg Med Chem; 2006 Sep; 14(17):6001-11. PubMed ID: 16843671
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT
J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452
[TBL] [Abstract][Full Text] [Related]
5. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
[TBL] [Abstract][Full Text] [Related]
6. Field interaction and geometrical overlap: a new simplex and experimental design based computational procedure for superposing small ligand molecules.
Melani F; Gratteri P; Adamo M; Bonaccini C
J Med Chem; 2003 Apr; 46(8):1359-71. PubMed ID: 12672236
[TBL] [Abstract][Full Text] [Related]
7. Retrospective docking study of PDE4B ligands and an analysis of the behavior of selected scoring functions.
Mpamhanga CP; Chen B; McLay IM; Ormsby DL; Lindvall MK
J Chem Inf Model; 2005; 45(4):1061-74. PubMed ID: 16045302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Pseudomonas aeruginosa deacetylase LpxC inhibitory activity of dual PDE4-TNFalpha inhibitors: a multiscreening approach.
Kadam RU; Garg D; Chavan A; Roy N
J Chem Inf Model; 2007; 47(3):1188-95. PubMed ID: 17458951
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
Srivani P; Srinivas E; Raghu R; Sastry GN
J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
[TBL] [Abstract][Full Text] [Related]
10. CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV.
Ducrot P; Andrianjara CR; Wrigglesworth R
J Comput Aided Mol Des; 2001 Sep; 15(9):767-85. PubMed ID: 11776290
[TBL] [Abstract][Full Text] [Related]
11. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
12. An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA.
Mascarenhas NM; Ghoshal N
Eur J Med Chem; 2008 Dec; 43(12):2807-18. PubMed ID: 18037537
[TBL] [Abstract][Full Text] [Related]
13. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
14. Critical assessment of the automated AutoDock as a new docking tool for virtual screening.
Park H; Lee J; Lee S
Proteins; 2006 Nov; 65(3):549-54. PubMed ID: 16988956
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of phosphodiesterase 4D and inhibitor complex(1).
Lee ME; Markowitz J; Lee JO; Lee H
FEBS Lett; 2002 Oct; 530(1-3):53-8. PubMed ID: 12387865
[TBL] [Abstract][Full Text] [Related]
16. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
[TBL] [Abstract][Full Text] [Related]
17. Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7.
Wang H; Liu Y; Chen Y; Robinson H; Ke H
J Biol Chem; 2005 Sep; 280(35):30949-55. PubMed ID: 15994308
[TBL] [Abstract][Full Text] [Related]
18. 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors.
Whitehead JW; Lee GP; Gharagozloo P; Hofer P; Gehrig A; Wintergerst P; Smyth D; McCoull W; Hachicha M; Patel A; Kyle DJ
J Med Chem; 2005 Feb; 48(4):1237-43. PubMed ID: 15715490
[TBL] [Abstract][Full Text] [Related]
19. Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase.
Huai Q; Sun Y; Wang H; Macdonald D; Aspiotis R; Robinson H; Huang Z; Ke H
J Med Chem; 2006 Mar; 49(6):1867-73. PubMed ID: 16539372
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
